MedPath

北京沃邦医药科技有限公司

Ownership
-
Established
2010-04-14
Employees
-
Market Cap
-
Website
www.vobanpharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

8

NMPA:8

Drug Approvals

Methocarbamol Injection

Product Name
美索巴莫注射液
Approval Number
国药准字H20254111
Approval Date
May 13, 2025
NMPA

Drotaverine Hydrochloride Injection

Product Name
盐酸屈他维林注射液
Approval Number
国药准字H20253760
Approval Date
Apr 1, 2025
NMPA

Carbocysteine Oral Solution

Product Name
羧甲司坦口服溶液
Approval Number
国药准字H20253732
Approval Date
Mar 25, 2025
NMPA

Nicorandil for Injection

Product Name
注射用尼可地尔
Approval Number
国药准字H20253491
Approval Date
Mar 4, 2025
NMPA

Nicorandil for Injection

Product Name
注射用尼可地尔
Approval Number
国药准字H20253492
Approval Date
Mar 4, 2025
NMPA

Carbocysteine Oral Solution

Product Name
羧甲司坦口服溶液
Approval Number
国药准字H20253350
Approval Date
Feb 8, 2025
NMPA

Nicorandil Tablets

Product Name
尼可地尔片
Approval Number
国药准字H20249805
Approval Date
Dec 25, 2024
NMPA

Sorbitol and Mannitol Irrigation Solution

Product Name
山梨醇甘露醇冲洗剂
Approval Number
国药准字H20233314
Approval Date
Dec 18, 2023
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.